- View all variations as list
CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
---|---|---|---|---|---|---|
NONRXDRUG-DR-XY24964-1pc
|
In stock
|
₱950 |
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
Sellers of this product
Features
- Loperamide
Description
Indications/Uses
Reduction of number and volume of discharge in patients with ileostomies and colostomies.
In addition to using loperamide for diarrhea, it is important to replace that fluid and salt loss with the use of oral rehydration solution (ORS) and/or by drinking plenty of fluids.
Dosage/Direction for Use
Or, as directed by a doctor.
Maximum dose is 16 mg (8 capsules) per day.
Discontinue if there is no improvement after 2 days.
For Symptomatic Relief of Chronic Diarrhea: Adult Dose: Take 2 capsules followed by 1 capsule after each loose bowel movement.
Then reduce loperamide dose to meet individual requirements. When the optimal daily dosage has been established, administer this amount as a single dose or in divided doses.
Or, as directed by a doctor.
Average Daily Maintenance Dose: Take 2 to 4 capsules/day. A dosage of five capsules (10 mg) is rarely exceeded.
If no clinical improvement is observed after treatment with 8 capsules/day (16 mg/day) for at least 10 days, symptoms are unlikely to be controlled by further loperamide administration.
Missed Dose: If the patient missed a dose, just take the next dose if still needed for diarrhea. Do not double the dose.
Overdosage
In adults, reported overdosage within 24 hours resulted in nausea after 40 mg (20 capsules) and vomiting after 60 mg (30 capsules).
If the patient has taken more than the recommended dosage (i.e., more than 8 capsules per day), consult a doctor or a Poison Control Center right away.
Administration
Contraindications
If it is for a child under 12 years old.
If the patient is pregnant or breastfeeding.
If the patient is constipated and also in whom constipation should be avoided (e.g., diarrhea resulting from infections).
If the abdomen is swollen or the patient has abdominal pain.
If the patient has acute dysentery which is characterized by blood in stools and high fever.
If the patient has pseudomembranous colitis (diarrhea associated with antibiotics), active ulcerative colitis, meningitis, or a history of liver disease.
Special Precautions
Stop use and consult the doctor if: Any undesirable effect occurs or acute diarrhea persists for more than two days, if symptoms worsen, if abdominal swelling or bulging develops, or if fever develops.
The patient has Acquired Immune Deficiency Syndrome (AIDS) and any signs of abdominal swelling or bulging. There have been isolated reports of toxic megacolon (rapid widening of the colon accompanied by infection or inflammation) in AIDS patients treated with loperamide.
A serious condition may develop if too much fluid has been lost by the body due to diarrhea. Consult a doctor if any of the following conditions develop: Decreased urination, Dizziness and lightheadedness, Dryness of mouth, Increased thirst, Wrinkled skin.
Use In Pregnancy & Lactation
Adverse Reactions
Allergic reactions including unexplained wheezing, shortness of breath, passing out, or swelling of the face and throat have occurred very rarely.
Undesirable effects involving the skin include pruritus (itch), rash, urticaria (hives) and extremely rare cases of angioedema (rapid swelling beneath the skin) and bullous (large skin blister) eruption including Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis (severe allergic reactions characterized by separation or exfoliation of tissue) have been rarely reported.